Neutrophil transendothelial migration potential predicts rejection severity in human cardiac transplantation

Healy, David G.; Watson, R. William G.; O’Keane, Conor; Egan, Jim J.; McCarthy, James F.; Hurley, John; Fitzpatrick, John; Wood, Alfred E.
May 2006
European Journal of Cardio-Thoracic Surgery;May2006, Vol. 29 Issue 5, p760
Academic Journal
Abstract: Objective: Transplant rejection remains a clinical problem despite therapies that focus on lymphocyte suppression, with little attention focused on the neutrophil. Neutrophils are however the first leukocyte to infiltrate the allograft, are capable of causing myocardial damage and may facilitate lymphocytes recruitment. We hypothesised that an early allograft neutrophil infiltration influences rejection severity. Methods: Myocardial neutrophil infiltration was assessed using CD15 and myeloperoxidase immunohistochemistry of rejection surveillance endomyocardial biopsy specimens from human cardiac transplant recipients (n =18). In patients undergoing cardiac transplantation (n =10), neutrophils were isolated from multiple perioperative blood samples using a ficoll-based density gradient centrifugation method. The expression of the neutrophil adhesion protein CD11b was then assessed using flow cytometry and compared to subsequent endomyocardial biopsy rejection grades. The effects of contemporary immunosuppressive agents on human neutrophil CD11b were also assessed using healthy control volunteers. Results: Myeloperoxidase staining of endomyocardial biopsies from human heart transplant recipients demonstrated a positive correlation between the degree of neutrophil infiltration and rejection severity at the first postoperative biopsy. Rejection severity was unrelated to ischaemic time. Functional assessment of neutrophils obtained from recipients was then performed. Perioperative transplant sampling demonstrated a significant correlation between the preoperative expression of CD11b and rejection grade at the first postoperative biopsy. In addition, dynamic changes in CD11b expression in the first 24h positively correlated with subsequent rejection severity. In vitro experiments showed that transplant immunosuppression did not alter neutrophil CD11b expression. Conclusion: This study demonstrates a potentially greater role for neutrophils in cardiac transplantation than previously recognised, and suggests that blockade of the early allograft neutrophil infiltration might prevent subsequent lymphocyte recruitment and attenuate rejection.


Related Articles

  • Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes. Joffre, Olivier; Santolaria, Thibault; Calise, Denis; Al Saati, Talal; Hudrisier, Denis; Romagnoli, Paola; van Meerwijk, Joost P. M. // Nature Medicine;Jan2008, Vol. 14 Issue 1, p88 

    A major challenge in transplantation medicine is controlling the very strong immune responses to foreign antigens that are responsible for graft rejection. Although immunosuppressive drugs efficiently inhibit acute graft rejection, a substantial proportion of patients suffer chronic rejection...

  • Biochemical and Pathological Study of Protective Effect of Vitamin E in Azathioprine-Induced Hepatotoxicity in Rat. Tabrizi, B. Amouoghli; Mohajeri, D.; Mousavi, G.; Farajzade, F.; Khodadadi, A.; Alizade, S. B.; Reihani, B. // Journal of Biological Sciences;2009, Vol. 9 Issue 4, p339 

    In the present research, we decided to study about the protective effect of vitamin E against Azathiprine-induced toxicity. In this study, 40 male Wistar rats were divided to 4 groups (each group contains 10 rats). For the first group, as the control one, normal saline was given. The second and...

  • High-Dose MMF Reduces Acute Rejection in African-Americans.  // Kidney;May/Jun98, Vol. 7 Issue 3, p125 

    Discusses the abstract of the research paper 'Immunosuppressive therapy in high-risk transplant patients,' by J.F. Neylan for the United States Transplant Mycophenolate Mofetil Study Group and published in a 1997 issue of the journal 'Transplantation.'

  • Unexplained Graft Dysfunction after Heart Transplantation--Role of Novel Molecular Expression Test Score and QTc-Interval: A Case Report. Shahzad, Khurram; Cadeiras, Martin; Arai, Kotaro; Abramov, Dmitry; Burke, Elizabeth; Deng, Mario C. // Cardiology Research & Practice;Jan2010, p1 

    In the current era of immunosuppressive medications there is increased observed incidence of graft dysfunction in the absence of known histological criteria of rejection after heart transplantation. A noninvasive molecular expression diagnostic test was developed and validated to rule out...

  • Rapamune.  // Royal Society of Medicine: Medicines;2002, p469 

    This article presents information on Rapamune, a proprietary, prescription-only preparation of the immunosuppressant sirolimus. It can be used to prevent tissue rejection in kidney transplant patients, and is available as an oral solution which is drunk after mixing with water or orange juice.

  • Belatacept: acute graft rejection.  // WHO Drug Information;2013, Vol. 27 Issue 2, p105 

    The article discusses a 2013 drug communication from Great Britain's Healthcare Products Regulatory Agency which discussed an announcement from the manufacturer of the drug belatacept in which the manufacturer noted an association between the drug and a risk of acute graft rejection.

  • Common medications prescribed for transplantation patients. Coleman, Adrian // Journal of Renal Nursing;Sep2013, Vol. 5 Issue 5, p222 

    Organ rejection is a major barrier to renal transplantation and the cost of immunosuppressants used for maintenance has been estimated at around £5000 per patient per year. In this article, pharmacist Adrian Coleman defines three classes of immunosuppressant medication, their mechanisms of...

  • Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. Sagoo, Pervinder; Perucha, Esperanza; Sawitzki, Birgit; Tomiuk, Stefan; Stephens, David A.; Miqueu, Patrick; Chapman, Stephanie; Craciun, Ligia; Sergeant, Ruhena; Brouard, Sophie; Rovis, Flavia; Jimenez, Elvira; Ballow, Amany; Giral, Magali; Rebollo-Mesa, Irene; Le Moine, Alain; Braudeau, Cecile; Hilton, Rachel; Gerstmayer, Bernhard; Bourcier, Katarzyna // Journal of Clinical Investigation;Jun2010, Vol. 120 Issue 6, p1848 

    Identifying transplant recipients in whom immunological tolerance is established or is developing would allow an individually tailored approach to their posttransplantation management. In this study, we aimed to develop reliable and reproducible in vitro assays capable of detecting tolerance in...

  • Clinical evidence on the use of anti-mTOR drugs in renal transplantation. Hernández, D.; Martínez, D.; Gutiérrez, E.; López, V.; Gutiérrez, C.; García, P.; Cobelo, C.; Cabello, M.; Burgos, D.; Sola, E.; González-Molina, M. // Nefrologia;2011, Vol. 31 Issue 1, p27 

    The calcineurin inhibitor drugs (CNI) are the mainstays of modern immunosuppression in renal transplantation, but they contribute significantly to the chronic graft loss and the high morbidity and mortality in this population for their deleterious effects on renal graft, cardiovascular profile...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics